NYSE$MPT

Medical Properties Trust Inc · Q4 2025 earnings

Q4 2025 earnings · · Before market open · Investor relations

Briefing

Medical Properties Trust reported Q4 2025, revenue of $270.3M, net income of $17M, diluted EPS of $0.03.

For Q4 2025, Medical Properties Trust reported revenue of $270.3M, net income of $17M, diluted EPS was $0.03. Management discusses segment performance, capital allocation, and outlook in the earnings filing.

  • Revenue $270.3M.
  • Net income $17M.
  • Diluted EPS $0.03.

Headline financials

Total Revenue

$270M

Previous: $232M+16.6%
EPS (adj)

$0.03

Previous: $0.18-83.3%
Net Income

$17M

Previous: -$412M+104.1%

Revenue & EPS history

Medical Properties Trust · Revenue · Quarterly

$270M

Q4 2025+16.6%vs Q4 2024
Beat estimate in 6 of 14 quarters(43%)
ActualEstimate

Revenue by segment

Medical Properties Trust · $307M total across 4 segments · Q3 2023

  • Rent Billed
    $229M-1.3%
  • Interest and Other Income
    $29.7M-29.9%
  • Income from Financing Leases
    $26.1M-48.9%
  • Straight-line Rent
    $21.5M-19.0%

Forward guidance

The release discusses Medical Properties Trust's outlook for upcoming periods, including capital allocation, operating priorities, and market risks, without relying solely on numeric EPS bridges.

Tailwinds

  • Medical Properties Trust cites operational execution and demand trends supporting the outlook.
  • Balance sheet and liquidity actions aim to fund growth and returns.
  • Dividends, NAV, and portfolio yields remain focal points for investors.

Headwinds

  • Macro, pricing, and input-cost volatility could pressure margins.
  • Segment mix and one-time items may affect quarter-to-quarter comparability.
  • Credit marks, non-accruals, and spread compression are key risks.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2025

Historical avgQ4 2025

+1.3%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+0.7%

Avg return

30 days after

65%

42 / 65 earnings

Positive

+17.0%

Q4 2024

Best reaction

-15.8%

Q2 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.6%-4.1%-6.0%
Q4 2025+12.1%+6.1%-15.1%
Q3 2025+6.6%+1.4%+18.5%
Q1 2025-6.9%-8.0%-17.2%
Q4 2024+17.0%+18.2%+26.6%
Q3 2024+7.0%-5.2%-9.8%
Q2 2024+1.5%+2.4%+7.4%
Q1 2024+7.2%+31.2%+20.4%
Q4 2023+2.5%+6.7%+13.9%
Q3 2023+9.9%+7.2%+4.7%
Q2 2023-15.8%-20.0%-33.4%
Q1 2023+10.6%+4.9%-0.1%
Q4 2022-13.5%-15.6%-38.3%
Q3 2022+6.8%+6.5%+20.6%
Q2 2022-5.3%-4.3%-15.3%
Q1 2022+4.1%+6.3%+5.2%
Q4 2021-4.0%-5.2%-10.2%
Q3 2021+0.1%-1.2%+1.5%
Q2 2021+1.3%-1.5%-3.3%
Q1 2021-2.0%-4.1%-5.9%
Q4 2020+0.0%+1.6%-2.9%
Q3 2020+3.7%+10.9%+13.8%
Q2 2020-0.8%-1.6%-8.5%
Q1 2020+4.1%+0.5%+9.8%
Q4 2019+2.3%+3.6%+1.1%
Q3 2019+1.2%-6.8%+0.9%
Q2 2019+2.1%-0.1%+6.2%
Q1 2019+3.8%+1.2%+2.0%
Q4 2018+3.4%+1.7%+1.1%
Q3 2018+3.2%+9.9%+16.2%
Q2 2018+1.0%+3.0%+4.2%
Q1 2018+1.8%+2.0%+5.6%
Q4 2017+1.6%+1.5%+6.6%
Q3 2017+3.2%+3.9%+4.8%
Q2 2017-1.7%+0.1%+5.2%
Q1 2017+2.1%+2.5%+4.3%
Q4 2016+1.8%+1.8%-6.3%
Q3 2016-0.8%+1.3%-2.7%
Q2 2016+1.1%+2.0%-0.5%
Q1 2016+3.8%
Q4 2015-2.5%
Q3 2015-3.4%
Q2 2015-3.8%
Q1 2015+2.9%
Q4 2014+0.4%
Q3 2014+2.7%
Q2 2014-0.3%
Q1 2014-0.9%
Q4 2013-0.4%
Q3 2013-0.7%
Q2 2013-2.8%
Q1 2013-1.0%
Q4 2012+1.1%
Q3 2012+3.1%
Q2 2012+0.7%
Q1 2012-0.1%
Q4 2011-0.6%
Q4 2009-0.6%
Q3 2011-4.4%
Q2 2011+4.5%
Q1 2011+2.8%
Q4 2010+2.8%
Q3 2010+0.5%
Q2 2010+1.0%
Q1 2010+7.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro